Millar D S, Wacey A I, Voke J, Kakkar V V, Cooper D N
Charter Molecular Genetics Laboratory, Thrombosis Research Institute, Chelsea, London, UK.
Blood Coagul Fibrinolysis. 1993 Aug;4(4):631-3. doi: 10.1097/00001721-199308000-00015.
A novel heterozygous GTG-->ATG (Val 297-->Met) substitution was detected in an individual with probable inherited protein C deficiency and both venous and arterial thrombotic disease. The lesion occurs in a highly conserved residue within the serine protease domain. In a molecular model of protein C, Met 297 makes unfavourable interactions with neighbouring residues suggesting that the mutant protein is unable to adopt a stable/functional conformation.
在一名可能患有遗传性蛋白C缺乏症且同时患有静脉和动脉血栓性疾病的个体中,检测到一种新的杂合性GTG→ATG(Val 297→Met)替代突变。该病变发生在丝氨酸蛋白酶结构域内一个高度保守的残基上。在蛋白C的分子模型中,Met 297与相邻残基产生不利相互作用,这表明突变蛋白无法形成稳定/功能性构象。